The role of fibrates in managing hyperlipidemia: mechanisms of action and clinical efficacy.

Abstract:

:At a time when the lipid management guidelines give more and more emphasis to the identification and treatment of high-risk patients with the metabolic syndrome and diabetes, there is an obvious need to balance the known effects of low-density lipoprotein (LDL) lowering with the new evidence of clinical efficacy derived from the adjustment of high-density lipoprotein (HDL) and triglyceride levels. Whereas the statins remain the drug of choice for patients who need to reach the LDL goal, fibrate therapy may represent the best intervention for subjects with atherogenic dyslipidemia and an LDL already close to goal. In addition, the concomitant use of fibrates may significantly reduce cardiovascular risk in patients whose LDL is controlled by statin therapy. In this review, we evaluate the pharmacologic properties of the fibrate drugs, with particular attention to the effects of peroxisome proliferator activated receptor a activation in the control of dyslipidemia as well as in the attenuation of arterial inflammation. Clinical trials of fibrates, such as the Helsinki Heart Study, Veterans Affairs High-density lipoprotein Intervention Trial, Diabetes Atherosclerosis Intervention Study, and Bezafibrate Infarction Prevention trial, have conjured up a scenario for the clinical utility of fibrates and their possible superiority to statins in the management of obese, insulin-resistant, and diabetic patients presenting with near-goal LDL and inappropriate HDL and triglyceride levels.

journal_name

Curr Atheroscler Rep

authors

Fazio S,Linton MF

doi

10.1007/s11883-004-0104-8

keywords:

subject

Has Abstract

pub_date

2004-03-01 00:00:00

pages

148-57

issue

2

eissn

1523-3804

issn

1534-6242

journal_volume

6

pub_type

杂志文章,评审
  • Imaging Atherosclerotic Plaque Calcification: Translating Biology.

    abstract::Calcification of atherosclerotic lesions was long thought to be an age - related, passive process, but increasingly data has revealed that atherosclerotic calcification is a more active process, involving complex signaling pathways and bone-like genetic programs. Initially, imaging of atherosclerotic calcification was...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-016-0601-6

    authors: Bailey G,Meadows J,Morrison AR

    更新日期:2016-08-01 00:00:00

  • Soy, garlic, and ginkgo biloba: their potential role in cardiovascular disease prevention and treatment.

    abstract::There are hundreds of foods, nutrients, herbs, and botanicals that have "bioactive" constituents with potential human health benefits. Three of these are discussed in this review: soy, garlic, and ginkgo biloba. Each of these three choices involves an ingestible item composed of a complex mixture of bioactive agents. ...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-003-0037-7

    authors: Gardner CD,Messina M,Lawson LD,Farquhar JW

    更新日期:2003-11-01 00:00:00

  • Carotid Atherosclerosis in Patients with Atrial Fibrillation.

    abstract:PURPOSE OF REVIEW:This review aims to explore the relationship between AF and carotid atherosclerosis, and the impact on the outcomes of cardiovascular and cerebrovascular events. Also, our aim is to critically review current knowledge and delineate future directions for effective treatment or prevention as well as str...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-019-0808-4

    authors: Wang Z,Korantzopoulos P,Liu T

    更新日期:2019-11-29 00:00:00

  • HDL hypothesis: where do we stand now?

    abstract::There is robust epidemiological evidence dating back to the original Framingham Heart Study from 1977 that indicates an important inverse relationship between high-density lipoprotein cholesterol (HDL-C) and risk of incident coronary artery disease (CAD). Despite this body of scientific information demonstrating that ...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-014-0398-0

    authors: Tariq SM,Sidhu MS,Toth PP,Boden WE

    更新日期:2014-04-01 00:00:00

  • Paroxysmal Atrial Fibrillation in Cryptogenic Stroke: an Overlooked Explanation?

    abstract::Approximately one third of ischemic strokes are labeled cryptogenic because the etiology is unknown despite a thorough evaluation. Paroxysmal atrial fibrillation carries the same risk of ischemic stroke as persistent atrial fibrillation and has increasingly gained attention as a potential source of cryptogenic stroke....

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-015-0547-0

    authors: Zhang C,Kasner SE

    更新日期:2015-12-01 00:00:00

  • Low-density lipoprotein apheresis in the treatment of atherosclerosis and other potential uses.

    abstract::This review concerns the clinical impact of low-density lipoprotein (LDL) apheresis for patients with refractory hypercholesterolemia. We examine and provide examples of investigations that have demonstrated the clinical benefits of LDL apheresis. In addition to benefits derived from the stabilization or regression of...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-001-0052-5

    authors: Moriarty PM,Gibson CA

    更新日期:2001-03-01 00:00:00

  • Antiatherogenic components of olive oil.

    abstract::Olive oil is the principal source of fat in the Mediterranean diet, which has been associated with a lower incidence of coronary heart disease and certain cancers. Olive oil is characterized by a high proportion of monounsaturated oleic acid, but the main peculiarity of extra-virgin oil is the presence of remarkable q...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-001-0012-0

    authors: Visioli F,Galli C

    更新日期:2001-01-01 00:00:00

  • Optimal therapy in hypertensive subjects with diabetes mellitus.

    abstract::Diabetes and its micro- and macrovascular complications represent a worldwide epidemic that will place an enormous financial burden on poorer countries in the years to come. In patients with diabetes and hypertension, the main determinant of the cardiovascular and renal benefits of antihypertensive drugs is the blood ...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-011-0160-9

    authors: Reboldi G,Gentile G,Angeli F,Verdecchia P

    更新日期:2011-04-01 00:00:00

  • Screening for hypercoagulable syndromes following stroke.

    abstract::Patients with ischemic stroke of unclear etiology are often screened for hypercoagulable syndromes or thrombophilias. These have been recognized to cause venous thrombosis, and include hereditary deficiencies of coagulation factors, genetic mutations, or acquired disorders. However, the majority of coagulation disorde...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-003-0052-8

    authors: Bushnell C,Goldstein LB

    更新日期:2003-07-01 00:00:00

  • Planning primary prevention of coronary disease.

    abstract::Effective prevention of the current annual $400 billion losses from atherosclerosis and cardiovascular disease (CVD) will require preventing primary causes rather than just decreasing signs and symptoms (risk factors) produced by those causes. All CVD risk factors predict a likelihood of CVD, but not all are causes of...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-009-0042-6

    authors: Lands B

    更新日期:2009-07-01 00:00:00

  • The role of matrix metalloproteinases in atherothrombosis.

    abstract::The matrix metalloproteinase (MMP) family of enzymes is involved in arterial wall extracellular matrix degradation and remodeling. The latter activities have been implicated in a number of normal and pathologic processes, such as atherosclerotic lesion formation and progression, plaque destabilization and rupture, but...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-010-0159-7

    authors: Ketelhuth DF,Bäck M

    更新日期:2011-04-01 00:00:00

  • Recent developments with lipoprotein-associated phospholipase A2 inhibitors.

    abstract::Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) is a calcium-independent phospholipase A(2) enzyme secreted by leukocytes and associated with circulating low-density lipoprotein and macrophages in atherosclerotic plaques. Until recently, the biological role of Lp-PLA(2) in atherosclerosis was controversial, but ...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-009-0076-9

    authors: Chauffe RJ,Wilensky RL,Mohler ER 3rd

    更新日期:2010-01-01 00:00:00

  • Should hyperhomocysteinemia be treated in patients with atherosclerotic disease?

    abstract::Numerous retrospective and prospective observational studies support an association between elevated homocysteine and increased risk for myocardial infarction, stroke, and peripheral vascular disease. Although folic acid therapy substantially reduces homocysteine levels, recent large, randomized controlled trials fail...

    journal_title:Current atherosclerosis reports

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/s11883-007-0048-x

    authors: Maron BA,Loscalzo J

    更新日期:2007-11-01 00:00:00

  • Patent foramen ovale and stroke: Should PFOs be closed in otherwise cryptogenic stroke?

    abstract::Since initial reports of its association with ischemic stroke appeared in 1988, there has been continued controversy regarding the existence and strength of the association between patent foramen ovale (PFO) and ischemic stroke. Many case-control studies have reported an association between incident cryptogenic ischem...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章

    doi:10.1007/s11883-010-0114-7

    authors: Carpenter DA,Ford AL,Lee JM

    更新日期:2010-07-01 00:00:00

  • Genetic determinants of plasma triglycerides: impact of rare and common mutations.

    abstract::Raised plasma triglyceride (TG) levels are an independent risk factor for coronary artery disease (CAD), and thus understanding the genetic and environmental determinants of TG levels are of major importance. TG metabolism is a process for delivering free fatty acids for energy storage or b-oxidation, and involves a n...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-001-0061-4

    authors: Talmud PJ

    更新日期:2001-05-01 00:00:00

  • Oxidative stress and atherosclerosis.

    abstract::Understanding of the pathophysiology of atherosclerosis can provide new strategies for the prevention and treatment of patients with this common disease. Clinical, epidemiologic, and basic molecular science studies have identified oxidative stress as a factor contributing to the development and progression of atherosc...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-005-0013-5

    authors: Schulze PC,Lee RT

    更新日期:2005-05-01 00:00:00

  • Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD.

    abstract:PURPOSE OF REVIEW:Apolipoprotein C-III (apoC-III) is known to inhibit lipoprotein lipase (LPL) and function as an important regulator of triglyceride metabolism. In addition, apoC-III has also more recently been identified as an important risk factor for cardiovascular disease. This review summarizes the mechanisms by ...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-019-0791-9

    authors: Taskinen MR,Packard CJ,Borén J

    更新日期:2019-05-20 00:00:00

  • Acute revascularization in ST-segment-elevation myocardial infarction.

    abstract::We briefly and comprehensively present some of the novel findings in the field of revascularization therapy and management of ST-segment-elevation myocardial infarction (STEMI). We highlight the latest evidence-based advancements in the pharmacological and mechanical treatment of patients who presented with STEMI. Sin...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-014-0412-6

    authors: Prodanov P,Widimsky P

    更新日期:2014-06-01 00:00:00

  • Psammomys obesus: a Natural Diet-Controlled Model for Diabetes and Cardiovascular Diseases.

    abstract:PURPOSE OF REVIEW:This review specifically summarises and reports terrestrial mammals of the gerbil subfamily, known as Israeli sand rats or Psammomys obesus (P. obesus) as a diet-controlled, unique, polygenic rodent model for research in the areas of obesity, type 2 diabetes, and cardiovascular diseases. The animal mo...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-018-0746-6

    authors: Chaudhary R,Walder KR,Hagemeyer CE,Kanwar JR

    更新日期:2018-07-17 00:00:00

  • Genetics of Arterial-Wall-Specific Mechanisms in Atherosclerosis: Focus on Mitochondrial Mutations.

    abstract:PURPOSE OF REVIEW:Mutations in both nuclear and mitochondrial genes are associated with the development of atherosclerotic lesions in arteries and may provide a partial explanation to the focal nature of lesion distribution in the arterial wall. This review is aimed to discuss the genetic aspects of atherogenesis with ...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-020-00873-5

    authors: Orekhov AN,Ivanova EA,Markin AM,Nikiforov NG,Sobenin IA

    更新日期:2020-08-09 00:00:00

  • Structural Basis for Vital Function and Malfunction of Serum Amyloid A: an Acute-Phase Protein that Wears Hydrophobicity on Its Sleeve.

    abstract:PURPOSE OF REVIEW:This review addresses normal and pathologic functions of serum amyloid A (SAA), an enigmatic biomarker of inflammation and protein precursor of AA amyloidosis, a life-threatening complication of chronic inflammation. SAA is a small, highly evolutionarily conserved acute-phase protein whose plasma leve...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-020-00888-y

    authors: Gursky O

    更新日期:2020-09-24 00:00:00

  • Postprandial hypertriglyceridemia and cardiovascular disease: current and future therapies.

    abstract::Exaggerated postprandial hypertriglyceridemia is a risk factor for cardiovascular disease. This metabolic abnormality is principally due to overproduction and/or decreased catabolism of triglyceride-rich lipoproteins (TRLs) and is a consequence of pathogenic genetic variations and other coexistent medical conditions, ...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-013-0309-9

    authors: Chan DC,Pang J,Romic G,Watts GF

    更新日期:2013-03-01 00:00:00

  • Aspirin for the Primary Prevention of Cardiovascular Disease: In Need of Clarity.

    abstract::Aspirin remains one of the most extensively studied cardiovascular medications in the history of medicine. However, despite multiple, well-designed, large randomized controlled trials evaluating the potential of aspirin to prevent cardiovascular events in individuals without known cardiovascular disease (CVD), the rol...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-015-0555-0

    authors: Miedema MD,Huguelet J,Virani SS

    更新日期:2016-01-01 00:00:00

  • Even "WISE-R?"-an Update on the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation.

    abstract:PURPOSE OF REVIEW:For over 20 years, the Women's Ischemia Syndrome Evaluation (WISE), a program sponsored by the National Heart, Lung, and Blood Institute, has explored diverse and important aspects of ischemic heart disease in women. RECENT FINDINGS:Women with symptoms and signs of ischemia but no significant epicard...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-020-00852-w

    authors: Barsky L,Merz CNB,Wei J,Shufelt C,Handberg E,Pepine C,Rutledge T,Reis S,Doyle M,Rogers W,Shaw L,Sopko G

    更新日期:2020-06-18 00:00:00

  • The high-risk plaque initiative: primary prevention of atherothrombotic events in the asymptomatic population.

    abstract::The High-Risk Plaque (HRP) Initiative is a research and development effort to advance the understanding, recognition, and management of asymptomatic individuals at risk for a near-term atherothrombotic event such as myocardial infarction or stroke. Clinical studies using the newest technologies have been initiated, in...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,随机对照试验

    doi:10.1007/s11883-011-0193-0

    authors: Falk E,Sillesen H,Muntendam P,Fuster V

    更新日期:2011-10-01 00:00:00

  • Cardiovascular disease in women.

    abstract::The rates of cardiovascular disease (CVD) have decreased significantly for men over the past few decades, but similar reductions have not occurred in women. Consequently, CVD remains the leading killer of women in the United States. Men usually develop heart disease earlier than women, but women develop heart disease ...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-008-0046-7

    authors: Lee LV,Foody JM

    更新日期:2008-08-01 00:00:00

  • Novel mechanisms of abdominal aortic aneurysms.

    abstract::Abdominal aortic aneurysms (AAAs) are a common but asymptomatic disease that has high susceptibility to rupture. Current therapeutic options are limited to surgical procedures because no pharmacological approaches have been proven to decrease either expansion or rupture of human AAAs. The current dearth of effective m...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-012-0271-y

    authors: Lu H,Rateri DL,Bruemmer D,Cassis LA,Daugherty A

    更新日期:2012-10-01 00:00:00

  • Modulation of the renin-angiotensin-aldosterone system in heart failure.

    abstract::The renin-angiotensin-aldosterone system (RAAS) is well-established and continues to be pursued as a therapeutic target in the treatment of heart failure, predominantly due to the success of agents that block RAAS in clinical trials of systolic heart failure. The optimal treatment of heart failure patients with preser...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-014-0403-7

    authors: George J,Struthers AD,Lang CC

    更新日期:2014-04-01 00:00:00

  • HDL as a Causal Factor in Atherosclerosis: Insights from Human Genetics.

    abstract::High-density lipoprotein cholesterol (HDL-C) levels are inversely related to risk of atherosclerotic cardiovascular disease (ASCVD). However, the simplistic assumption that HDL-C levels directly and causally impact atherogenesis has been challenged in recent years. The purpose of this article is to review the current ...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-016-0623-0

    authors: Brunham LR

    更新日期:2016-12-01 00:00:00

  • Genome-wide association studies in atherosclerosis.

    abstract::Cardiovascular disease remains the major cause of worldwide morbidity and mortality. Its pathophysiology is complex and multifactorial. Because the phenotype of cardiovascular disease often shows a marked heritable pattern, it is likely that genetic factors play an important role. In recent years, large genome-wide as...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-011-0173-4

    authors: Sivapalaratnam S,Motazacker MM,Maiwald S,Hovingh GK,Kastelein JJ,Levi M,Trip MD,Dallinga-Thie GM

    更新日期:2011-06-01 00:00:00